295 related articles for article (PubMed ID: 32534033)
1. Tadalafil versus linaclotide in gastrointestinal dysfunction and depressive behavior in constipation-predominant irritable bowel syndrome.
Sedky AA; Magdy Y
Life Sci; 2020 Sep; 256():117960. PubMed ID: 32534033
[TBL] [Abstract][Full Text] [Related]
2. Review article: Linaclotide for the management of irritable bowel syndrome with constipation.
Layer P; Stanghellini V
Aliment Pharmacol Ther; 2014 Feb; 39(4):371-84. PubMed ID: 24433216
[TBL] [Abstract][Full Text] [Related]
3. Linaclotide inhibits colonic nociceptors and relieves abdominal pain via guanylate cyclase-C and extracellular cyclic guanosine 3',5'-monophosphate.
Castro J; Harrington AM; Hughes PA; Martin CM; Ge P; Shea CM; Jin H; Jacobson S; Hannig G; Mann E; Cohen MB; MacDougall JE; Lavins BJ; Kurtz CB; Silos-Santiago I; Johnston JM; Currie MG; Blackshaw LA; Brierley SM
Gastroenterology; 2013 Dec; 145(6):1334-46.e1-11. PubMed ID: 23958540
[TBL] [Abstract][Full Text] [Related]
4. Sildenafil normalizes bowel transit in preclinical models of constipation.
Sharman SK; Islam BN; Hou Y; Usry M; Bridges A; Singh N; Sridhar S; Rao S; Browning DD
PLoS One; 2017; 12(4):e0176673. PubMed ID: 28448580
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic properties, metabolism, and disposition of linaclotide, a novel therapeutic peptide approved for the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
Busby RW; Kessler MM; Bartolini WP; Bryant AP; Hannig G; Higgins CS; Solinga RM; Tobin JV; Wakefield JD; Kurtz CB; Currie MG
J Pharmacol Exp Ther; 2013 Jan; 344(1):196-206. PubMed ID: 23090647
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacological and clinical profile of linaclotide (Linzess
Keto Y; Kosako M
Nihon Yakurigaku Zasshi; 2019; 153(6):289-298. PubMed ID: 31178535
[TBL] [Abstract][Full Text] [Related]
7. Effect of 5 days linaclotide on transit and bowel function in females with constipation-predominant irritable bowel syndrome.
Andresen V; Camilleri M; Busciglio IA; Grudell A; Burton D; McKinzie S; Foxx-Orenstein A; Kurtz CB; Sharma V; Johnston JM; Currie MG; Zinsmeister AR
Gastroenterology; 2007 Sep; 133(3):761-8. PubMed ID: 17854590
[TBL] [Abstract][Full Text] [Related]
8. Linaclotide: a novel agent for chronic constipation and irritable bowel syndrome.
Love BL; Johnson A; Smith LS
Am J Health Syst Pharm; 2014 Jul; 71(13):1081-91. PubMed ID: 24939497
[TBL] [Abstract][Full Text] [Related]
9. Linaclotide, through activation of guanylate cyclase C, acts locally in the gastrointestinal tract to elicit enhanced intestinal secretion and transit.
Busby RW; Bryant AP; Bartolini WP; Cordero EA; Hannig G; Kessler MM; Mahajan-Miklos S; Pierce CM; Solinga RM; Sun LJ; Tobin JV; Kurtz CB; Currie MG
Eur J Pharmacol; 2010 Dec; 649(1-3):328-35. PubMed ID: 20863829
[TBL] [Abstract][Full Text] [Related]
10. Linaclotide increases cecal pH, accelerates colonic transit, and increases colonic motility in irritable bowel syndrome with constipation.
Farmer AD; Ruffle JK; Hobson AR
Neurogastroenterol Motil; 2019 Feb; 31(2):e13492. PubMed ID: 30353623
[TBL] [Abstract][Full Text] [Related]
11. Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report.
Rey E; Mearin F; Alcedo J; Ciriza C; Delgado-Aros S; Freitas T; Mascarenhas M; Mínguez M; Santos J; Serra J
Adv Ther; 2017 Mar; 34(3):587-598. PubMed ID: 28083815
[TBL] [Abstract][Full Text] [Related]
12. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
Johnston JM; Shiff SJ; Quigley EM
Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Tolerability of Guanylate Cyclase-C Agonists for Irritable Bowel Syndrome with Constipation and Chronic Idiopathic Constipation: A Systematic Review and Meta-Analysis.
Shah ED; Kim HM; Schoenfeld P
Am J Gastroenterol; 2018 Mar; 113(3):329-338. PubMed ID: 29380823
[TBL] [Abstract][Full Text] [Related]
14. Linaclotide: a review of its use in the treatment of irritable bowel syndrome with constipation.
McCormack PL
Drugs; 2014 Jan; 74(1):53-60. PubMed ID: 24293117
[TBL] [Abstract][Full Text] [Related]
15. Linaclotide-a novel secretagogue in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation.
Sharma S; Sharma T; Dhingra R; Tomar P; Singh S; Malhotra M; Bhardwaj TR
Mini Rev Med Chem; 2013 Oct; 13(11):1685-90. PubMed ID: 24001336
[TBL] [Abstract][Full Text] [Related]
16. Linaclotide in irritable bowel syndrome with constipation: A Phase 3 randomized trial in China and other regions.
Yang Y; Fang J; Guo X; Dai N; Shen X; Yang Y; Sun J; Bhandari BR; Reasner DS; Cronin JA; Currie MG; Johnston JM; Zeng P; Montreewasuwat N; Chen GZ; Lim S
J Gastroenterol Hepatol; 2018 May; 33(5):980-989. PubMed ID: 29319191
[TBL] [Abstract][Full Text] [Related]
17. Safety and tolerability of linaclotide for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation: pooled Phase 3 analysis.
Nee JW; Johnston JM; Shea EP; Walls CE; Tripp K; Shiff S; Fox SM; Bochenek W; Weissman D; Currie MG; Lembo AJ
Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):397-406. PubMed ID: 30791771
[TBL] [Abstract][Full Text] [Related]
18. Effect of linaclotide in irritable bowel syndrome with constipation (IBS-C): a systematic review and meta-analysis.
Atluri DK; Chandar AK; Bharucha AE; Falck-Ytter Y
Neurogastroenterol Motil; 2014 Apr; 26(4):499-509. PubMed ID: 24351035
[TBL] [Abstract][Full Text] [Related]
19. Linaclotide: a novel compound for the treatment of irritable bowel syndrome with constipation.
Rothstein RD; Friedenberg FK
Expert Opin Pharmacother; 2013 Oct; 14(15):2125-32. PubMed ID: 24007408
[TBL] [Abstract][Full Text] [Related]
20. Effect of linaclotide on severe abdominal symptoms in patients with irritable bowel syndrome with constipation.
Rao SS; Quigley EM; Shiff SJ; Lavins BJ; Kurtz CB; MacDougall JE; Currie MG; Johnston JM
Clin Gastroenterol Hepatol; 2014 Apr; 12(4):616-23. PubMed ID: 24075889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
